BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22133874)

  • 1. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
    Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R
    J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
    EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNMT3B7 expression related to MENT expression and its promoter methylation in human lymphomas.
    Alkebsi L; Handa H; Sasaki Y; Osaki Y; Yanagisawa K; Ogawa Y; Yokohama A; Hattori H; Koiso H; Saitoh T; Mitsui T; Tsukamoto N; Nojima Y; Murakami H
    Leuk Res; 2013 Dec; 37(12):1662-7. PubMed ID: 24094886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
    Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
    Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
    Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA
    Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
    J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.
    Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R
    Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
    Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
    Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
    Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
    Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of DNA methyltransferase 3B depletion are not associated with DNA demethylation.
    Hagemann S; Kuck D; Stresemann C; Prinz F; Brueckner B; Mund C; Mumberg D; Sommer A
    PLoS One; 2012; 7(5):e36125. PubMed ID: 22563479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
    Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
    Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E
    Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
    Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
    Okano M; Bell DW; Haber DA; Li E
    Cell; 1999 Oct; 99(3):247-57. PubMed ID: 10555141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells.
    Beetch M; Boycott C; Harandi-Zadeh S; Yang T; Martin BJE; Dixon-McDougall T; Ren K; Gacad A; Dupuis JH; Ullmer M; Lubecka K; Yada RY; Brown CJ; Howe LJ; Stefanska B
    J Nutr Biochem; 2021 Dec; 98():108815. PubMed ID: 34242723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions.
    Nowialis P; Lopusna K; Opavska J; Haney SL; Abraham A; Sheng P; Riva A; Natarajan A; Guryanova O; Simpson M; Hlady R; Xie M; Opavsky R
    Nat Commun; 2019 Sep; 10(1):4374. PubMed ID: 31558711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
    Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
    Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ∆ DNMT3B4-del Contributes to Aberrant DNA Methylation Patterns in Lung Tumorigenesis.
    Ma MZ; Lin R; Carrillo J; Bhutani M; Pathak A; Ren H; Li Y; Song J; Mao L
    EBioMedicine; 2015 Oct; 2(10):1340-50. PubMed ID: 26629529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair.
    Trinh BN; Long TI; Nickel AE; Shibata D; Laird PW
    Mol Cell Biol; 2002 May; 22(9):2906-17. PubMed ID: 11940649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer.
    Qiu W; Lin J; Zhu Y; Zhang J; Zeng L; Su M; Tian Y
    Cell Physiol Biochem; 2017; 41(4):1325-1335. PubMed ID: 28278502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.